Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.64 |
| ▸ | PPARG | P37231 | 2/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.34 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.32 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.32 |
| ▸ | PRKCA | P17252 | 3/20 | 0.31 |
| ▸ | ABHD16A | O95870 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2597466 | 1.00 | CYP1A2 (0.64) | CYP1A2PPARGCA1CA9EPHX2 | |
| SCHEMBL8578070 | 1.00 | CYP1A2 (0.64) | CYP1A2PPARGCA1CA9EPHX2 | |
| SCHEMBL8576864 | 1.00 | CYP1A2 (0.64) | CYP1A2PPARGCA1CA9EPHX2 | |
| SCHEMBL2597438 | 1.00 | CYP1A2 (0.64) | CYP1A2PPARGCA1CA9EPHX2 | |
| SCHEMBL272754 | 0.94 | CYP1A2 (0.58) | CYP1A2PPARGCA1CA9CYP19A1 | |
| SCHEMBL19275487 | 0.87 | CYP1A2 (0.53) | CYP1A2PPARGCA1CA9 | |
| SCHEMBL8573551 | 0.86 | CYP1A2 (0.67) | CYP1A2PPARGCA1CA9EPHX2 | |
| SCHEMBL8574308 | 0.86 | CYP1A2 (0.67) | CYP1A2PPARGCA1CA9EPHX2 | |
| SCHEMBL2597398 | 0.84 | CYP1A2 (0.64) | CYP1A2PPARGCA1CA9EPHX2 | |
| SCHEMBL2597424 | 0.84 | CYP1A2 (0.64) | CYP1A2PPARGCA1CA9EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2571380-A1 | 5-ALKENYL-2-OXO-TETRAHYDROFURANE DERIVATIVES AS FLAVORING COMPOUNDS | Firmenich SA (CH) | 2013-03-27 | — | — | EP | claimed |
| US-20130034646-A1 | 5-ALKENYL-2-OXO-TETRAHYDROFURANE DERIVATIVES AS FLAVORING COMPOUNDS | FIRMENICH SA (CH) | 2013-02-07 | — | — | US | claimed |
| WO-2011145048-A1 | 5-ALKENYL-2-OXO-TETRAHYDROFURANE DERIVATIVES AS FLAVORING COMPOUNDS | FIRMENICH SA (CH) | 2011-11-24 | — | — | WO | claimed |
| EP-4583708-A1 | ARTHROPOD CONTROL COMPOSITIONS | Firmenich SA (CH) | 2025-07-16 | — | — | EP | disclosed |
| WO-2024084006-A1 | ARTHROPOD CONTROL COMPOSITIONS | FIRMENICH SA (CH) | 2024-04-25 | — | — | WO | disclosed |
| EP-2571380-B1 | 5-Alkenyl-2-oxo-tetrahydrofurane derivatives as flavoring compounds | FIRMENICH & CIE (CH) | 2016-04-20 | — | — | EP | disclosed |
| EP-2571380-A1 | 5-ALKENYL-2-OXO-TETRAHYDROFURANE DERIVATIVES AS FLAVORING COMPOUNDS | Firmenich SA (CH) | 2013-03-27 | — | — | EP | disclosed |
| US-20130034646-A1 | 5-ALKENYL-2-OXO-TETRAHYDROFURANE DERIVATIVES AS FLAVORING COMPOUNDS | FIRMENICH SA (CH) | 2013-02-07 | — | — | US | disclosed |
| WO-2011145048-A1 | 5-ALKENYL-2-OXO-TETRAHYDROFURANE DERIVATIVES AS FLAVORING COMPOUNDS | FIRMENICH SA (CH) | 2011-11-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130034646-A1 | 5-ALKENYL-2-OXO-TETRAHYDROFURANE DERIVATIVES AS FLAVORING COMPOUNDS | FABP5, ACSL5, TAS2R5 | CYP1A2 819/4885PPARG 447/4885CA1 3723/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.